Basic HTML-Version
226
Allgemein-, Viszeral- und Transplantationschirurgie
liver transplantation in Germany - limitations of
the ‚sickest first‘-concept.,Transpl Int.,24(1),91-99
233. Weitz J, Reissfelder C,
Kolorektales Karzinomrisi-
ko: Langzeiteffekt einer täglichen Einnahme von
Aspirin,Chirurgische Allgemeine.,12(4),279-280
234. Welsch T, Schneider M, Büchler MW,
Langenbeck‘s
archives of surger y 2011: new concepts and
design.,Langenbecks Arch Surg.,396(1),1.
235. Welsch, L., T. Welsch, D. I. Dovzhanskiy, K. Felix,
N. A. Giese, D. V. Krysko and J. Werner ,
Impact
of the histone deacetylase inhibitor 4-phenylbu-
tyrate on the clearance of apoptotic pancreatic
carcinoma cells by human macrophages.,Int J On-
col.,40, 427-35.
236. Welsch, T., H. Eisele, S. Zschabitz, U. Hinz, M. W.
Buchler and M. N. Wente ,
Critical appraisal of the
International Study Group of Pancreatic Surgery
(ISGPS) consensus definition of postoperative he-
morrhage after pancreatoduodenectomy.,Langen
becks Arch Surg.,396, 353-62.
237. Welsch, T., L. Degrate, S. Zschabitz, S. Hofer, J.
Werner and J. Schmidt ,
The need for extended in-
tensive care after pancreaticoduodenectomy for
pancreatic ductal adenocarcinoma.,Langenbecks
Arch Surg.,396, 783-91.
238. Welsch, T., M. von Frankenberg, J . Schmidt
and M. W. Buchler ,
[Diagnosis and def initi-
on of anastomotic leakage from the surgeon‘s
perspective].,Chirurg.,82, 48-55.
239. Welsch, T., S. Zschabitz, V. Becker, T. Giese, F.
Bergmann, U. Hinz, S. Keleg, A. Heller, B. Sipos,
U. Klingmuller, M. W. Buchler, J. Werner and N. A.
Giese ,
Prognostic significance of erythropoietin in
pancreatic adenocarcinoma.,PLoS One.,6, e23151.
240. Werner J, Hartwig W, Hackert T, Kaiser H, Schmidt
J, Gebhard MM, Büchler MW, Klar E.,
Multidrug
strategies are effective in the treatment of severe
experimental pancreatitis.,Surgery.,97(9),733-9
241. Werner, J. and M. W. Buchler ,
[Pancreatic necrosis:
pro surgical therapy].,Chirurg.,82, 507-13.
242. Wild B, Herzog W, Wesche D, Niehoff D, Müller B,
Hain B.,
Development of a group therapy to enhan-
ce treatment motivation and decision making in
severely obese patients with a comorbid mental
disorder,Obes Surg.,21(5),588-94
243. Wolf ND, Kadmon M, Wolf RC, Brechtel A, Keller
M.,
Quality of life after restorative proctocolecto-
my and ileal pouch-anal anastomosis in patients
with familial adenomatous polyposis: a matter of
adjustment.,Colorectal Dis.,13(11),e 358-65
244. Wölfl C, Takur C, Moghaddam AA, Zimmermann G,
Hitzler M, Schmidt-Gayk H, Höner B, Grützner PA,
Kolios L.,
[The Ludwigshafen Osteoporosis Scree-
ning Questionnaire (LOS Questionnaire) : Result of
the evaluation of anamnestic risk factors in oste-
oporosis diagnostics.],Unfallchirurg.,[Epub ahead
of print],
245. Zahn, A., N. Schott, U. Hinz, W. Stremmel, J.
Schmidt, T. Ganten, D. Gotthardt, S. Meuer, M.
Zeier, T. Giese and C. Sommerer ,
Immunomonito-
ring of nuclear factor of activated T cells-regulated
gene expression: the first clinical trial in liver allo-
graft recipients.,Liver Transpl.,17, 466-73.
246. Zhang M, Herion TW, Timke C, Han N, Hauser K,
WeberTrimodal glioblastoma treatment consi-
sting of concurrent radiotherapy, temozolomide,
and the novel TGF-
β
receptor I kinase inhibitor
LY2109761 KJ, Peschke P, Wirkner U, Lahn M, Hu-
ber PE.,,Neoplasia.,13(6),537-549
247. Zimmermann G, Moghaddam A . ,
A l log r af t
bone mat r i x ver sus synthet ic bone g r af t
substitutes,Injury.,42 Suppl 2,S16-21
248. Z
immermann G, Schmeckenbecher KH, Bo-
euf S, Weiss S, Bock R, Moghaddam A, Richter
W.,
Differential gene expression analysis in frac-
ture callus of patients with regular and failed bone
healing,Injury.,43(3),347-56
249. Zöller M.,
CD44: can a cancer-initiating cell profit
from an abundantly expressed molecule,Nat Rev
Cancer.,11,254-267